Michael Freeman: Hi. Good morning, Mike and James and Shayne. Thanks very much for taking questions. I wanted to first ask, we have a great interest in your partnership with Ginkgo Bioworks and the commercialization of rares. I wonder after many quarters selling rare in a — distributed through your products. I wondered if you could describe at a high level the impact you've seen as it relates to sales and market penetration of these rares.